Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.80)
# 3,315
Out of 4,534 analysts
14
Total ratings
75%
Success rate
3.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintained: Hold | $26 → $29 | $26.58 | +9.10% | 3 | May 7, 2026 | |
| ATRC AtriCure | Downgraded: Hold | $48 → $36 | $34.77 | +3.54% | 4 | Feb 10, 2026 | |
| XRAY DENTSPLY SIRONA | Reiterated: Hold | n/a | $13.46 | - | 2 | Dec 19, 2025 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $4.23 | +18.20% | 5 | Nov 7, 2025 |
Envista Holdings
May 7, 2026
Maintained: Hold
Price Target: $26 → $29
Current: $26.58
Upside: +9.10%
AtriCure
Feb 10, 2026
Downgraded: Hold
Price Target: $48 → $36
Current: $34.77
Upside: +3.54%
DENTSPLY SIRONA
Dec 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $13.46
Upside: -
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $4.23
Upside: +18.20%